Verici Dx plc (LON:VRCI – Get Free Report)’s stock price was down 8% during trading on Monday . The stock traded as low as GBX 1.04 ($0.01) and last traded at GBX 1.04 ($0.01). Approximately 328,583 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 959,091 shares. The stock had previously closed at GBX 1.13 ($0.02).
Verici Dx Stock Performance
The company has a debt-to-equity ratio of 4.64, a quick ratio of 8.49 and a current ratio of 4.54. The company’s 50-day moving average price is GBX 1.49 and its 200 day moving average price is GBX 2.61. The stock has a market capitalization of £3.14 million, a PE ratio of -0.60 and a beta of 1.59.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- What Investors Need to Know About Upcoming IPOs
- RH Stock Rockets on Surprise Profit and Tariff Shift
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- How to Invest in the Best Canadian Stocks
- Alphabet Enters a Bull Market: Is It Time to Buy?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
